Buy Or Sell Opportunity • Apr 15
Now 21% undervalued Over the last 90 days, the stock has risen 23% to €1.07. The fair value is estimated to be €1.35, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%. Price Target Changed • Jan 27
Price target increased by 63% to €0.85 Up from €0.52, the current price target is provided by 1 analyst. New target price is 10% below last closing price of €0.95. Stock is up 127% over the past year. The company posted a net loss per share of €0.12 last year. New Risk • Dec 12
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 40% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€11.8m market cap, or US$13.8m). Announcement • Oct 22
Egide S.A. Provides Earnings Guidance for the Second Half of 2025 Egide S.A. provided earnings guidance for the second half of 2025. For the second half, the Group expects revenue to grow in the second half of 2025 (H2 2025), driven by: Egide SA: continued commercial recovery as experienced in H1, with an expansion of the customer base in the European and North American markets; Egide USA: continued growth momentum in high value-added segments; Santier: active search for new opportunities to offset the end of major contracts, but weak activity is expected to persist in H2. Announcement • Aug 06
Egide S.A., Annual General Meeting, Sep 10, 2025 Egide S.A., Annual General Meeting, Sep 10, 2025. Location: site industriel du sactar, bollene France Announcement • Jul 03
Egide S.A. Announces CEO Changes After four years at Egide S.A. announced David HIEN will leave the EGIDE Group and his position as CEO on July 31, 2025. The Board of Directors, meeting on July 1st, 2025, under the chairmanship of Philippe BENSUSSAN, announced the appointment of Ignace DUPON as Group CEO, effective August 1, 2025. This appointment is part of an operational and strategic continuity, with Ignace DUPON having held key positions within the Group for more than ten years and currently leading US operations as General Manager of Egide USA since 2023 and Santier since 2024. With a civil engineering degree in electronics and management from the University of Leuven (KUL), Ignace DUPON is known for his leadership, strategic vision, and ability to grow businesses in complex international markets. International executive with over 30 years' experience in the high-tech and industrial sectors, he has held key positions within the Egide Group since 2014: Sales Director for Europe and Asia, then in the U.S. as Purchasing Director and now as GM of the Cambridge and San Diego (MD) sites. At EGIDE, he has led major strategic transformations including a return to profitability, client portfolio diversification, industrial restructuring, and the development of strategic accounts. Prior to Egide, he held senior purchasing, commercial and business development roles at Keopsys, Highwave Optical Technologies, and Alcatel Optronics, where he built international teams and negotiated industrial partnerships. Announcement • Jun 17
Egide S.A. to Report Fiscal Year 2024 Final Results on Jun 30, 2025 Egide S.A. announced that they will report fiscal year 2024 final results at 5:40 PM, Central European Standard Time on Jun 30, 2025 Reported Earnings • May 04
Full year 2024 earnings released Full year 2024 results: Revenue: €30.0m (down 18% from FY 2023). Net loss: €2.48m (loss narrowed 21% from FY 2023). Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Electronic industry in France. New Risk • Apr 08
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €8.12m (US$8.87m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 21% per year over the past 5 years. Market cap is less than US$10m (€8.12m market cap, or US$8.87m). Minor Risk Shareholders have been diluted in the past year (21% increase in shares outstanding). New Risk • Mar 03
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 21% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (21% increase in shares outstanding). Market cap is less than US$100m (€9.57m market cap, or US$10.0m). New Risk • Jan 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 47% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (€8.43m market cap, or US$8.67m). New Risk • Nov 12
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 10.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10.0% average weekly change). Market cap is less than US$10m (€6.72m market cap, or US$7.13m). Minor Risk Shareholders have been diluted in the past year (22% increase in shares outstanding). Announcement • Nov 12
Egide S.A. has filed a Follow-on Equity Offering in the amount of €1.695104 million. Egide S.A. has filed a Follow-on Equity Offering in the amount of €1.695104 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 2,607,853
Price\Range: €0.65
Transaction Features: Subsequent Direct Listing New Risk • Sep 16
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Market cap is less than US$10m (€6.21m market cap, or US$6.91m). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Shareholders have been diluted in the past year (22% increase in shares outstanding). New Risk • Jul 27
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 9.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.6% average weekly change). Shareholders have been substantially diluted in the past year (57% increase in shares outstanding). Market cap is less than US$10m (€6.41m market cap, or US$6.96m). Reported Earnings • Jul 12
Full year 2023 earnings released: €0.19 loss per share (vs €0.033 profit in FY 2022) Full year 2023 results: €0.19 loss per share (down from €0.033 profit in FY 2022). Revenue: €37.0m (up 139% from FY 2022). Net loss: €3.12m (down €3.46m from profit in FY 2022). Revenue is forecast to grow 3.8% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in France. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 37 percentage points per year, which is a significant difference in performance. Announcement • Jun 19
Egide S.A. to Report Fiscal Year 2023 Results on Jul 15, 2024 Egide S.A. announced that they will report fiscal year 2023 results at 12:00 PM, Central European Standard Time on Jul 15, 2024 New Risk • Jun 13
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.27m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (27% accrual ratio). Shareholders have been substantially diluted in the past year (57% increase in shares outstanding). Market cap is less than US$10m (€9.27m market cap, or US$9.95m). Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). New Risk • May 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (27% accrual ratio). Shareholders have been substantially diluted in the past year (57% increase in shares outstanding). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (7.0% average weekly change). Market cap is less than US$100m (€10.7m market cap, or US$11.6m). New Risk • Apr 26
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.24m (US$9.88m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (27% accrual ratio). Shareholders have been substantially diluted in the past year (57% increase in shares outstanding). Market cap is less than US$10m (€9.24m market cap, or US$9.88m). Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change). Price Target Changed • Jan 31
Price target decreased by 18% to €0.95 Down from €1.16, the current price target is provided by 1 analyst. New target price is 27% above last closing price of €0.75. Stock is up 34% over the past year. The company posted earnings per share of €0.033 last year. New Risk • Jan 31
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). High level of non-cash earnings (27% accrual ratio). High level of non-cash earnings (27% accrual ratio). Shareholders have been substantially diluted in the past year (57% increase in shares outstanding). Minor Risk Market cap is less than US$100m (€12.2m market cap, or US$13.2m). New Risk • Jan 25
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 57% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (27% accrual ratio). High level of non-cash earnings (27% accrual ratio). Shareholders have been substantially diluted in the past year (57% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Market cap is less than US$100m (€14.7m market cap, or US$16.0m). Announcement • Nov 23
Egide S.A. has filed a Follow-on Equity Offering. Egide S.A. has filed a Follow-on Equity Offering.
Security Name: Shares
Security Type: Common Stock
Transaction Features: Rights Offering Reported Earnings • Nov 06
First half 2023 earnings released: €0.086 loss per share (vs €0.20 loss in 1H 2022) First half 2023 results: €0.086 loss per share (improved from €0.20 loss in 1H 2022). Revenue: €19.3m (up 21% from 1H 2022). Net loss: €888.0k (loss narrowed 56% from 1H 2022). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Electronic industry in France. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Price Target Changed • Oct 26
Price target increased by 20% to €1.16 Up from €0.97, the current price target is provided by 1 analyst. New target price is 100% above last closing price of €0.58. The company posted earnings per share of €0.033 last year. New Risk • Sep 08
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 29% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Share price has been highly volatile over the past 3 months (11% average weekly change). High level of non-cash earnings (35% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (2.2% net profit margin). Shareholders have been diluted in the past year (29% increase in shares outstanding). Market cap is less than US$100m (€10.1m market cap, or US$10.8m). Announcement • Sep 07
Egide S.A. has completed a Follow-on Equity Offering in the amount of €1.921561 million. Egide S.A. has completed a Follow-on Equity Offering in the amount of €1.921561 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 2,956,248
Price\Range: €0.65
Transaction Features: Rights Offering Announcement • Sep 06
Egide S.A. to Report First Half, 2023 Results on Oct 26, 2023 Egide S.A. announced that they will report first half, 2023 results on Oct 26, 2023 Announcement • Jul 22
Egide S.A. Provides Sales Guidance for the Second Half of 2023 Egide S.A. provided sales guidance for the second half of 2023. Driven by strong sales momentum across all products in first half of 2023, the company intends to maintain a similar level of revenue in the second half of 2023. New Risk • Jul 12
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.2% Last year net profit margin: 4.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Share price has been highly volatile over the past 3 months (15% average weekly change). High level of non-cash earnings (35% accrual ratio). Market cap is less than US$10m (€6.96m market cap, or US$7.75m). Minor Risk Profit margins are more than 30% lower than last year (2.2% net profit margin). Announcement • May 05
An unknown buyer signed a non-binding letter of intent to acquire Egide USA, Inc. from Egide S.A. (ENXTPA:ALGID). An unknown buyer signed a non-binding letter of intent to acquire Egide USA, Inc. from Egide S.A. (ENXTPA:ALGID) on May 3, 2023. Price Target Changed • Nov 16
Price target decreased to €0.78 Down from €1.13, the current price target is provided by 1 analyst. New target price is 41% above last closing price of €0.56. Stock is down 54% over the past year. The company posted earnings per share of €0.019 last year. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Jul 06
Full year 2021 earnings released: EPS: €0.019 (vs €0.095 in FY 2020) Full year 2021 results: EPS: €0.019 (down from €0.095 in FY 2020). Revenue: €32.5m (up 8.4% from FY 2020). Net income: €201.0k (down 80% from FY 2020). Profit margin: 0.6% (down from 3.3% in FY 2020). Over the next year, revenue is forecast to grow 12%, compared to a 28% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 04
Full year 2021 earnings released Full year 2021 results: Revenue: €32.5m (up 8.4% from FY 2020). Net income: €50.0k (down 95% from FY 2020). Profit margin: 0.2% (down from 3.3% in FY 2020). Over the next year, revenue is forecast to grow 12%, compared to a 27% growth forecast for the industry in France. Valuation Update With 7 Day Price Move • Feb 28
Investor sentiment improved over the past week After last week's 27% share price gain to €1.50, the stock trades at a trailing P/E ratio of 12.7x. Average forward P/E is 17x in the Electronic industry in France. Total returns to shareholders of 26% over the past three years. Valuation Update With 7 Day Price Move • Jan 20
Investor sentiment improved over the past week After last week's 17% share price gain to €1.74, the stock trades at a trailing P/E ratio of 14.7x. Average forward P/E is 18x in the Electronic industry in France. Total returns to shareholders of 34% over the past three years. Valuation Update With 7 Day Price Move • Dec 13
Investor sentiment improved over the past week After last week's 30% share price gain to €1.40, the stock trades at a trailing P/E ratio of 11.9x. Average forward P/E is 16x in the Electronic industry in France. Total loss to shareholders of 3.8% over the past three years. Valuation Update With 7 Day Price Move • Jun 16
Investor sentiment improved over the past week After last week's 16% share price gain to €1.57, the stock trades at a trailing P/E ratio of 16.5x. Average forward P/E is 17x in the Electronic industry in France. Total loss to shareholders of 32% over the past three years. Is New 90 Day High Low • Dec 23
New 90-day high: €1.15 The company is up 42% from its price of €0.81 on 23 September 2020. The French market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 24% over the same period. Is New 90 Day High Low • Oct 08
New 90-day high: €0.88 The company is up 14% from its price of €0.77 on 09 July 2020. The French market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is down 6.0% over the same period.